By ThinkSabio #ThinkSabio Latest News
Company Description: Pasithea Therapeutics Corp., a biotechnology company, engages in discovery, research, and development of treatments for central nervous system disorders, RASopathies, and other diseases. Its lead product candidate PAS-004, a next-generation macrocyclic mitogen-activated protein kinase
News: Pasithea Therapeutics Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules